Cargando…

On the way of the new strategies aimed to improve the efficacy of PD-1/PD-L1 immune checkpoint blocking mAbs in small cell lung cancer

Detalles Bibliográficos
Autores principales: Correale, Pierpaolo, Giannicola, Rocco, Saladino, Rita Emilena, Nardone, Valerio, Pirtoli, Luigi, Tassone, Pierfrancesco, Luce, Amalia, Cappabianca, Salvatore, Scrima, Marianna, Tagliaferri, Pierosandro, Caraglia, Michele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7653153/
https://www.ncbi.nlm.nih.gov/pubmed/33209592
http://dx.doi.org/10.21037/tlcr-20-536
_version_ 1783607844143104000
author Correale, Pierpaolo
Giannicola, Rocco
Saladino, Rita Emilena
Nardone, Valerio
Pirtoli, Luigi
Tassone, Pierfrancesco
Luce, Amalia
Cappabianca, Salvatore
Scrima, Marianna
Tagliaferri, Pierosandro
Caraglia, Michele
author_facet Correale, Pierpaolo
Giannicola, Rocco
Saladino, Rita Emilena
Nardone, Valerio
Pirtoli, Luigi
Tassone, Pierfrancesco
Luce, Amalia
Cappabianca, Salvatore
Scrima, Marianna
Tagliaferri, Pierosandro
Caraglia, Michele
author_sort Correale, Pierpaolo
collection PubMed
description
format Online
Article
Text
id pubmed-7653153
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-76531532020-11-17 On the way of the new strategies aimed to improve the efficacy of PD-1/PD-L1 immune checkpoint blocking mAbs in small cell lung cancer Correale, Pierpaolo Giannicola, Rocco Saladino, Rita Emilena Nardone, Valerio Pirtoli, Luigi Tassone, Pierfrancesco Luce, Amalia Cappabianca, Salvatore Scrima, Marianna Tagliaferri, Pierosandro Caraglia, Michele Transl Lung Cancer Res Editorial AME Publishing Company 2020-10 /pmc/articles/PMC7653153/ /pubmed/33209592 http://dx.doi.org/10.21037/tlcr-20-536 Text en 2020 Translational Lung Cancer Research. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Editorial
Correale, Pierpaolo
Giannicola, Rocco
Saladino, Rita Emilena
Nardone, Valerio
Pirtoli, Luigi
Tassone, Pierfrancesco
Luce, Amalia
Cappabianca, Salvatore
Scrima, Marianna
Tagliaferri, Pierosandro
Caraglia, Michele
On the way of the new strategies aimed to improve the efficacy of PD-1/PD-L1 immune checkpoint blocking mAbs in small cell lung cancer
title On the way of the new strategies aimed to improve the efficacy of PD-1/PD-L1 immune checkpoint blocking mAbs in small cell lung cancer
title_full On the way of the new strategies aimed to improve the efficacy of PD-1/PD-L1 immune checkpoint blocking mAbs in small cell lung cancer
title_fullStr On the way of the new strategies aimed to improve the efficacy of PD-1/PD-L1 immune checkpoint blocking mAbs in small cell lung cancer
title_full_unstemmed On the way of the new strategies aimed to improve the efficacy of PD-1/PD-L1 immune checkpoint blocking mAbs in small cell lung cancer
title_short On the way of the new strategies aimed to improve the efficacy of PD-1/PD-L1 immune checkpoint blocking mAbs in small cell lung cancer
title_sort on the way of the new strategies aimed to improve the efficacy of pd-1/pd-l1 immune checkpoint blocking mabs in small cell lung cancer
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7653153/
https://www.ncbi.nlm.nih.gov/pubmed/33209592
http://dx.doi.org/10.21037/tlcr-20-536
work_keys_str_mv AT correalepierpaolo onthewayofthenewstrategiesaimedtoimprovetheefficacyofpd1pdl1immunecheckpointblockingmabsinsmallcelllungcancer
AT giannicolarocco onthewayofthenewstrategiesaimedtoimprovetheefficacyofpd1pdl1immunecheckpointblockingmabsinsmallcelllungcancer
AT saladinoritaemilena onthewayofthenewstrategiesaimedtoimprovetheefficacyofpd1pdl1immunecheckpointblockingmabsinsmallcelllungcancer
AT nardonevalerio onthewayofthenewstrategiesaimedtoimprovetheefficacyofpd1pdl1immunecheckpointblockingmabsinsmallcelllungcancer
AT pirtoliluigi onthewayofthenewstrategiesaimedtoimprovetheefficacyofpd1pdl1immunecheckpointblockingmabsinsmallcelllungcancer
AT tassonepierfrancesco onthewayofthenewstrategiesaimedtoimprovetheefficacyofpd1pdl1immunecheckpointblockingmabsinsmallcelllungcancer
AT luceamalia onthewayofthenewstrategiesaimedtoimprovetheefficacyofpd1pdl1immunecheckpointblockingmabsinsmallcelllungcancer
AT cappabiancasalvatore onthewayofthenewstrategiesaimedtoimprovetheefficacyofpd1pdl1immunecheckpointblockingmabsinsmallcelllungcancer
AT scrimamarianna onthewayofthenewstrategiesaimedtoimprovetheefficacyofpd1pdl1immunecheckpointblockingmabsinsmallcelllungcancer
AT tagliaferripierosandro onthewayofthenewstrategiesaimedtoimprovetheefficacyofpd1pdl1immunecheckpointblockingmabsinsmallcelllungcancer
AT caragliamichele onthewayofthenewstrategiesaimedtoimprovetheefficacyofpd1pdl1immunecheckpointblockingmabsinsmallcelllungcancer